Seattle Genetics Inc /wa Files 8-K : Results of Operations and Financial Condition, Financial Statements and Exhibits, ... Seattle Genetics Inc /wa, based in BOTHELL, WA, filed an 8-K statement with the U.S. Securities Exchange Commission today.
SHARE THIS:
SHORT URL: http://bdvt.co/lAq
MEDIA
No media uploaded.
INFO
About
Seattle Genetics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases in the United States. Its lead product, SGN-35 is in pivotal trial stage used for the treatment of patients with relapsed or refractory hodgkin lymphoma. The company
SEC Filing $SGEN Seattle Genetics Inc.
Seattle Genetics Inc /wa, based in BOTHELL, WA, filed an 8-K statement with the U.S. Securities Exchange Commission today.